Clinical Trial Update: Nobori Dual Antiplatelet Therapy as Appropriate Duration [Phase 4]

View source ↗

Summary

A Phase 4 trial update reports on the appropriate duration of Nobori Dual Antiplatelet Therapy for coronary artery disease, with the study status indicating com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Nobori Dual Antiplatelet Therapy

Snippet

Sponsor: Associations for Establishment of Evidence in Interventions | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED